The content of this article is more than 5 years old. Please be aware that information provided may no longer be accurate, up-to-date, or relevant.
Alta Charo served on the organizing committee for the "Allocation of Monoconal Antibody Therapies and Other Novel Therapeutics" workshop. She also moderated a workshop panel, "Equitable Allocation for Underserved and Marginlized Populations."
Submitted by Law School News on December 17, 2020
This article appears in the categories: Activities & Scholarship
Related employee profiles: R. Alta Charo
